MedPath

Development of a novel method for prognostic prediction and precision medicine in pancreatic adenocarcinoma using fine-needle biopsy tissues collected from intraoperative specime

Not Applicable
Recruiting
Conditions
Pancreatic cancer
Registration Number
JPRN-UMIN000040972
Lead Sponsor
The Jikei University School of Medicine
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
All
Target Recruitment
30
Inclusion Criteria

Not provided

Exclusion Criteria

1. Inoperable case (e.g., caricninomatosa was found out) during surgery. 2. Patient with mental disease and it is difficult to participate in study. 3. Patints who refuse to participate in this study.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Evaluation of the correlation between immunohistochemistry-scores and novel quantitative analysis for Smad4.
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath